These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 11069207)

  • 21. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.
    Rossetti P; Porcellati F; Busciantella Ricci N; Candeloro P; Cioli P; Nair KS; Santeusanio F; Bolli GB; Fanelli CG
    Diabetes; 2008 Jul; 57(7):1905-17. PubMed ID: 18390791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
    Lewis GF; Carpentier A; Bilinski D; Giacca A; Vranic M
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1037-46. PubMed ID: 10084592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects.
    Kerr D; MacDonald IA; Tattersall RB
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1118-22. PubMed ID: 2656734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients.
    Russell RR; Chyun D; Song S; Sherwin RS; Tamborlane WV; Lee FA; Pfeifer MA; Rife F; Wackers FJ; Young LH
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1029-36. PubMed ID: 11595660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.
    Enoksson S; Caprio SK; Rife F; Shulman GI; Tamborlane WV; Sherwin RS
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1503-11. PubMed ID: 12679430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.
    Israelian Z; Szoke E; Woerle J; Bokhari S; Schorr M; Schwenke DC; Cryer PE; Gerich JE; Meyer C
    Metabolism; 2006 May; 55(5):593-8. PubMed ID: 16631434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
    Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.
    Landstedt-Hallin L; Adamson U; Lins PE
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3140-5. PubMed ID: 10487677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
    Degn KB; Brock B; Juhl CB; Djurhuus CB; Grubert J; Kim D; Han J; Taylor K; Fineman M; Schmitz O
    Diabetes; 2004 Sep; 53(9):2397-403. PubMed ID: 15331551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
    Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
    Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of etomoxir on insulin sensitivity in type 2 diabetic patients.
    Hübinger A; Weikert G; Wolf HP; Gries FA
    Horm Metab Res; 1992 Mar; 24(3):115-8. PubMed ID: 1577399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).
    Bolli GB; Gottesman IS; Campbell PJ; Haymond MW; Cryer PE; Gerich JE
    N Engl J Med; 1984 Nov; 311(19):1214-9. PubMed ID: 6387483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia.
    Schmid SM; Hallschmid M; Jauch-Chara K; Bandorf N; Born J; Schultes B
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3044-51. PubMed ID: 17519315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for inhibition of leptin secretion by catecholamines in man.
    Fritsche A; Wahl HG; Metzinger E; Renn W; Kellerer M; Häring H; Stumvoll M
    Exp Clin Endocrinol Diabetes; 1998; 106(5):415-8. PubMed ID: 9831308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.